Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$410,000 |
 |
Gilead SciencesGILD |
-$1.19B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$98M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Nuss John | Apr 2, 2025 | Sell | 1,887 | $1.07 | $2,000 |
| Nuss John | Dec 27, 2024 | Sell | 21,119 | $2.36 | $50,000 |
| Gujrathi Sheila | Dec 23, 2024 | Buy | 130,000 | $2.3121 | $300,000 |
| Nuss John | Dec 19, 2024 | Sell | 13,161 | $2.2553 | $30,000 |
| Mohan Raju | Nov 25, 2024 | Buy | 261,752 | $2.0055 | $520,000 |
| Mohan Raju | Nov 22, 2024 | Buy | 238,248 | $1.8256 | $430,000 |
| Krueger Christopher W | Apr 2, 2024 | Sell | 1,651 | $5.4036 | $8,900 |
| Nuss John | Apr 2, 2024 | Sell | 1,651 | $5.4034 | $8,900 |
| Mohan Raju | Apr 2, 2024 | Sell | 4,312 | $5.4034 | $23,000 |
| Auster Martin | Apr 2, 2024 | Sell | 1,405 | $5.4035 | $7,600 |
| Nuss John | Dec 20, 2023 | Sell | 17,628 | $2.1179 | $37,000 |
| Mohan Raju | Dec 20, 2023 | Sell | 58,860 | $2.1179 | $120,000 |
| Krueger Christopher W | Dec 20, 2023 | Sell | 5,293 | $2.1179 | $11,000 |
| NSV Partners III GP LLC | Oct 9, 2023 | Sell | 49,152 | $30.0264 | $1.5M |
| Subramaniam Somu | Oct 9, 2023 | Sell | 49,152 | $30.0264 | $1.5M |
What's the latest insider transaction for Ventyx Biosciences?
The most recent insider transaction for Ventyx Biosciences was conducted by Nuss John, who sold 1,887 shares on April 2, 2025 at a price of $1.07 per share.
Which insider bought the most VTYX stock over the last two years?
Mohan Raju has bought the most VTYX stock in the last 2 years, with a total value of $960,000.
Which insider has sold the most VTYX stock over the last two years?
Subramaniam Somu has sold the most VTYX stock in the last 2 years, with a total value of $1.5M.
What is the total value of insider transactions for Ventyx Biosciences (VTYX) in the last 2 years?
The total value of insider transactions for Ventyx Biosciences in the last 2 years is negative, amounting to -$2M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Ventyx Biosciences' market confidence?
Over the last 2 years, insider transactions for Ventyx Biosciences have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
